Pfizer and BioNTech Win FDA Clearance for This Fall's COVID Shot
The 2026-2027 vaccine targets the XFG variant and began shipping immediately. The next day, BioNTech ended a cancer trial and shares fell.
ticker-bntx
1 storyCoverage
The 2026-2027 vaccine targets the XFG variant and began shipping immediately. The next day, BioNTech ended a cancer trial and shares fell.
One email each trading morning. Free.